Comparison of three treatment regimens of inhaled sodium cromoglycate in the management of adult patients with severe, steroid-dependent asthma

Annals of Allergy, Asthma and Immunology

Volumn 80, Issue 6, 1998, Pages 494-498

  Sakai, Hiroyuki ^a   Shimoda, Terufumi ^a   Matsuo, Nobuko ^a   Matsuse, Hirohito ^a   Obase, Yasushi ^a   Asai, Sadahiro ^b   Kohno, Shigeru ^a   Edwards, Alan ^c,d  

^a NAGASAKI UNIVERSITY   (Japan)

^b Sasebo Shiritsu Sogo Hospital   (Japan)

^c SOUTHAMPTON GENERAL HOSPITAL   (United Kingdom)

^d NONE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BECLOMETASONE DIPROPIONATE; CORTICOSTEROID; CROMOGLYCATE DISODIUM; PREDNISOLONE; SALBUTAMOL;

ADULT; AGED; ARTICLE; ASTHMA; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORTICOSTEROID THERAPY; FEMALE; HUMAN; INHALATIONAL DRUG ADMINISTRATION; MALE; METERED DOSE INHALER; NEBULIZER; ORAL DRUG ADMINISTRATION; PEAK EXPIRATORY FLOW; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME;

EID: 0031858534     PISSN: 10811206     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1081-1206(10)63073-6     Document Type: Article

References (18)

1. Edwards AM. Sodium cromoglycate (Intal) as an anti-inflammatory agent for the treatment of chronic asthma. Clin Exp Allergy 1994;24:612-23.
2. Altounyan REC, Howell JBL. Treatment of asthma with disodium cromoglycate (FPL 670, 'Intal'). Respiration 1969;26 Suppl:131-40.
3. Brompton Hospital/Medical Research Council Collaborative Trial. Long-term study of disodium cromoglycate in treatment of severe extrinsic or intrinsic bronchial asthma in adults. Br Med J 1972;11:383-8.
4. Chai H, Molk L, Falliers CJ, Miklich D. Steroid-sparing effects of disodium cromoglycate (DSCG) in children with severe chronic asthma. In: Serafini et al, eds. New concepts in allergy & clinical immunology, Proc 7th Int Congr Allergology Florence 1970; Rome: CEPI 1971 385-91.
5. Read J, Rebuck AS. Steroid-sparing effect of disodium cromoglycate ("Intal") in chronic asthma. Med J Aust 1969;1:566-9.
6. Furusho K, Nishikawa K, Sasaki S, et al. A multi-centre controlled study of the efficacy of regularly inhaled cromolyn sodium and salbutamol in children with severe intractable asthma. Shonika Rinsho 1991;44:173-92.
7. Makino S. Guidelines for the treatment of allergic diseases. Life Sci Medica 1993;7-8.
8. Yamamura Y, Shida R, Mitsui S, et al. Japanese Society of Allergology. Bronchial asthma severity. Jpn J Allergol 1993;32:1186-99.
9. Moran F, Bankier JDG, Boyd G. Disodium cromoglycate in the treatment of allergic bronchial asthma. Lancet 1968;2:137.
10. Toogood JH, Lefcoe NM, Rose DK, McCourtie DR. A double-blind study of disodium cromoglycate for prophylaxis of bronchial asthma. Am Rev Respir Dis 1971;104:323.
11. Mathieson DA, Condemi JJ, Lovejoy FW, Vaughan JH. Cromolyn treatment of asthma. JAMA 1971;216(9): 1454-8.
12. Toogood JH, McCourtie DR, Jennings BH, et al. Changes in corticosteroid usage by chronic asthma patients during a year of cromoglycate treatment. J Allergy Clin Immunol 1973;52(6): 334-45.
13. Newman SP, Clark AR, Talaee N, Clarke SW. Pressurised aerosol deposition in the human lung with and without an "open" spacer device. Thorax 1989;44(9):706-10.
14. Thomas SHL, O'Doherty MJ, Page CJ, et al. Which apparatus for inhaled pentamidine? A comparison of pulmonary deposition via eight nebulisers. Eur Respir J 1991;4:616-22.
15. Salmon B, Wilson NM, Silverman M. How much aerosol reaches the lungs of wheezy infants and toddlers. Arch Dis Child 1990;65:401-3.
16. Hoshino M, Nakamura Y. The effect of disodium cromoglycate (DSCG) on infiltration of inflammatory cells into bronchial mucosa and on expression of adhesion molecules in asthma. Aerugi 1995;44:593-601.
17. Hoshino M, Nakamura Y. Anti-inflammatory effects of inhaled beclomethasone diproprionate in nonatopic asthmatics. Eur Respir J 1996;9: 696-702.
18. Norris AA, Alton EWF. Chloride transport and the action of sodium cromoglycate and nedocromil sodium in asthma. Clin Exp Allergy 1996;26: 250-3.